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Influenza is considered a major threat to human health. The current influenza vaccines production system in 
embryonated eggs does not satisfy the market needs in cases of pandemic or high seasonal demand. 
Furthermore, even though the existent seasonal vaccines are effective to induce protective immunity in healthy 
adults, poor immunogenicity in the elderly and early childhood is elicited (Wu et al., 2010). Therefore, there is a 
need to develop new generation influenza vaccines produced in robust and flexible production platforms capable 
of providing complete immune protection and support the vaccines demand. Virus-like particles (VLP) constitute 
a promising alternative to safely elicit a potent immune response against influenza. These particles do not contain 
viral genome and their structure mimic influenza virus (Thompson et al., 2015). In this study, a HEK-293SF 
inducible stable cell line expressing hemagglutinin (HA) and neuraminidase (NA) of the strain A/PR/8/34 (H1N1) 
has been developed. Once the stable cell line, named 293HA/NA, was established, the production of VLPs was 
mediated by transient transfection with the plasmid pAdCMV5-GAGGFP that encodes the HIV GAG structural 
protein fused with GFP. The transient expression of GAG was efficient to abundantly release the particles in the 
culture medium. The VLPs production in 293HA/NA cells using GAGGFP protein as scaffold was studied in 250 
mL shake flasks by following the increase of fluorescence in the supernatant (Spectrophotometry) and the 
accumulation of HA (Dot-Blot) (Figure 1). The process was successfully operated in a 3L-Bioreactor and at 72h 
post-transfection the cell supernatant was 
ultracentrifuged on a 25 % sucrose cushion. High levels 
of well-structured influenza GAG-VLPs were obtained 
by this production process and their concentration was 
estimated by electron microscopy at 5.9*109 VLPs/mL. 
The influenza GAG-VLPs were purified by Tangential 
Flow Filtration and the concentration of HA was 
estimated by three different techniques: Single Radial 
Immunodiffusion, Hemagglutination assay and Dot-
Blot. With further optimization, the production system 
proposed in this work could be a promising alternative 
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Figure 1 – Kinetic of expression of GFP and HA during 
the production of influenza GAG-VLPs in 293HA/NA 
stable cell line.  
